Divested.
Swave develops holographic eXtended reality technology to make virtual reality practically indistinguishable from the real world.
THERAtRAME develops and positions new therapeutics targeting tRNA epitranscriptomics in cancer.
ABSCINT is developing single-domain antibodies for disease diagnosis through imaging.
